Exonic
AI for precision gene therapy
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- exonic.ai
- Total Funding
- $500K
- Last Round
- $500K SeedNov 2025
About
Exonic, backed by Y Combinator (F25), builds AI systems for precision gene therapy and the next generation of drug discovery. The company is focused on applying artificial intelligence to accelerate therapeutic development, with a strong focus on precision oncology. Based in San Francisco, Exonic raised $5M to support regulatory submissions and expand into new markets.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account